Stevanato S.p.a (STVN) Stock
Leading supplier of glass vials and syringes for medicines. Here's the price, business snapshot, and what's worth knowing about Stevanato S.p.a in October 2026.
Stevanato Group S.p.A. (STVN) is an Italian-based supplier of primary packaging and drug containment solutions for the pharmaceutical and biotechnology industries. The company produces glass vials, syringes, cartridges and other sterile containment systems, and offers assembly and inspection services to customers developing vaccines, biologics and injectable medicines. With a market capitalisation of about $7.19 billion, Stevanato’s performance is linked to global pharmaceutical demand, adoption of advanced delivery formats and regulatory standards for sterile packaging. The business is capital-intensive and benefits from long-term customer contracts, but faces risks such as raw material costs, currency fluctuations and customer concentration. Investors should weigh growth prospects from biologics and onshoring trends against cyclical healthcare spending and execution risks. This content is educational only and not personal advice; values can fall as well as rise, and past performance is not a reliable indicator of future returns.
Stevanato S.p.a (STVN) Stock Forecast
Analyst price target, next 12 months
$26.20
+35.3% vs today's $19.37
Price range over the last 12 months
In the middle of its 12-month range
Analysts covering Stevanato S.p.a have a consensus 12-month target of $26.20, above the current price of $19.37.
Analyst targets are opinions, not guarantees. Capital at risk. Data as of 8 Oct 2026.
Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Stevanato Group's stock, believing it could rise to $26.2.
Financial Health
Stevanato Group is generating solid revenue and cash flow, indicating a stable financial position.
Dividend
Stevanato Group's low dividend yield of 0.3% indicates limited income for investors. If you invested $1000 you would be paid $3.00 a year in dividends (based on the last 12 months).
Why You’ll Want to Watch This Stock
Strong demand drivers
Rising biologics and injectable therapies support long-term demand, though growth depends on customer contracts and industry cycles.
Global manufacturing reach
A footprint across regions helps serve multinational pharma firms, but also exposes the company to currency and supply-chain risks.
Innovation and risks
Investments in advanced containment and inspection can create competitive edge; however, the business is capital-intensive and execution matters.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
